AAAAAA

   
Results: 1-19 |
Results: 19
COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX (VOL 31, PG 473, 1998)
Authors: KHAN IH CAMPBELL MK CANTAROVICH D CATTO GRD DELCROIX C EDWARD N FONTENAILLE C VANHAMERSVELT HW HENDERSON IS KOENE RAP PAPADIMITRIOU M RITZ E RAMSAY C TSAKIRIS D MACLEOD AM
Citation: Ih. Khan et al., COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX (VOL 31, PG 473, 1998), American journal of kidney diseases, 31(5), 1998, pp. 900-900
COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX
Authors: KHAN IH CAMPBELL MK CATAROVICH D CATTO GRD DELCROIX C EDWARD N FONTENAILLE C VANHAMERSVELT HW HENDERSON IS KOENE RAP PAPADIMITRIOU M RITZ E RAMSAY C TSAKIRIS D MACLEOD AM
Citation: Ih. Khan et al., COMPARING OUTCOMES IN RENAL REPLACEMENT THERAPY - HOW SHOULD WE CORRECT FOR CASE-MIX, American journal of kidney diseases, 31(3), 1998, pp. 473-478
THE BEST TIMING OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION INANEMIA OF PREMATURITY - A RANDOMIZED CONTROLLED-STUDY
Authors: KREMENOPOULOS G SOUBASI V TSANTALI C DIAMANTI E TSAKIRIS D
Citation: G. Kremenopoulos et al., THE BEST TIMING OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION INANEMIA OF PREMATURITY - A RANDOMIZED CONTROLLED-STUDY, International journal of pediatric hematology/oncology, 4(4), 1997, pp. 373-383
THE RENAL CONSEQUENCES OF ARTERIAL-HYPERTENSION
Authors: MOUNTOKALAKIS TD MADIAS NE HARRINGTON JT RENNKE HG VOSNIDES G SYMVOULIDOU D GREKAS D EMMANOUEL DS CHRISTIDOU F LASARIDIS A BOLETIS J STEFANIDIS C TSAKIRIS D
Citation: Td. Mountokalakis et al., THE RENAL CONSEQUENCES OF ARTERIAL-HYPERTENSION, Kidney international, 51(5), 1997, pp. 1639-1653
RARE DISEASES IN RENAL REPLACEMENT THERAPY IN THE ERA-EDTA REGISTRY
Authors: TSAKIRIS D SIMPSON HKL JONES EHP BRIGGS JD ELINDER CG MENDEL S PICCOLI G DOSSANTOS JP TOGNONI G VANRENTERGHEM Y VALDERRABANO F
Citation: D. Tsakiris et al., RARE DISEASES IN RENAL REPLACEMENT THERAPY IN THE ERA-EDTA REGISTRY, Nephrology, dialysis, transplantation, 11, 1996, pp. 4-20
SURVIVAL ON RENAL REPLACEMENT THERAPY IN EUROPE - IS THERE A CENTER EFFECT
Authors: KHAN IH CAMPBELL MK CANTAROVICH D CATTO GRD DELCROIX C EDWARD N FONTENAILLE C FLEMING LW GERLAG PGG VANHAMERSVELT HW HENDERSON IS KOENE RAP PAPADIMITRIOU M RITZ E RUSSELL IT STIER E TSAKIRIS D MACLEOD AM
Citation: Ih. Khan et al., SURVIVAL ON RENAL REPLACEMENT THERAPY IN EUROPE - IS THERE A CENTER EFFECT, Nephrology, dialysis, transplantation, 11(2), 1996, pp. 300-307
INDUCTION OF FETAL HEMOGLOBIN BY EPO GIVEN IN PRETERM NEONATES FOR THE PREVENTION OF ANEMIA OF PREMATURITY
Authors: SOUBASI V KREMENOPOULOS G DIAMANTI E TSANTALI C SARAFIDIS K TSAKIRIS D
Citation: V. Soubasi et al., INDUCTION OF FETAL HEMOGLOBIN BY EPO GIVEN IN PRETERM NEONATES FOR THE PREVENTION OF ANEMIA OF PREMATURITY, International journal of pediatric hematology/oncology, 2(3), 1995, pp. 205-209
VARIATIONS IN OUTCOME IN RENAL REPLACEMENT THERAPY (RRT) IN EUROPE - IS THERE A CENTER EFFECT - (BIOMED-1 SURVIVAL STUDY)
Authors: KHAN IH CAMPBELL M CANTAROVICH D CATTO G EDWARD N VANHAMERSVELT H HENDERSON I KOENE R PAPADIMITRIOU M TSAKIRIS D RITZ E MACLEOD A
Citation: Ih. Khan et al., VARIATIONS IN OUTCOME IN RENAL REPLACEMENT THERAPY (RRT) IN EUROPE - IS THERE A CENTER EFFECT - (BIOMED-1 SURVIVAL STUDY), Journal of the American Society of Nephrology, 6(3), 1995, pp. 540-540
THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ON OVERALL REDUCTION OF ERYTHROCYTE TRANSFUSIONS IN PRETERM INFANTS
Authors: SOUBASI V KREMENOPOULOS G DIAMANDI E SARAFIDIS K TSANTALI C TSAKIRIS D
Citation: V. Soubasi et al., THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ON OVERALL REDUCTION OF ERYTHROCYTE TRANSFUSIONS IN PRETERM INFANTS, Pediatric research, 37(4), 1995, pp. 238-238
FOLLOW-UP OF VERY-LOW-BIRTH-WEIGHT INFANTS AFTER ERYTHROPOIETIN TREATMENT TO PREVENT ANEMIA OF PREMATURITY
Authors: SOUBASI V KREMENOPOULOS G DIAMANTI E TSANTALI C SARAFIDIS K TSAKIRIS D
Citation: V. Soubasi et al., FOLLOW-UP OF VERY-LOW-BIRTH-WEIGHT INFANTS AFTER ERYTHROPOIETIN TREATMENT TO PREVENT ANEMIA OF PREMATURITY, The Journal of pediatrics, 127(2), 1995, pp. 291-297
INFLUENCE OF DEATHS IN THE 1ST 90 DAYS ON COMPARATIVE SURVIVAL-DATA ON RENAL REPLACEMENT THERAPY (RRT) - THE BIOMED-1 SURVIVAL STUDY
Authors: KHAN IH CAMPBELL M CANTAROVICH D CATTO G EDWARD N VANHAMERSVELT H HENDERSON I KOENE R PAPADIMITRIOU M TSAKIRIS D RITZ E MACLEOD AM
Citation: Ih. Khan et al., INFLUENCE OF DEATHS IN THE 1ST 90 DAYS ON COMPARATIVE SURVIVAL-DATA ON RENAL REPLACEMENT THERAPY (RRT) - THE BIOMED-1 SURVIVAL STUDY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 458-458
EARLY DIAGNOSIS OF AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD) - EVALUATION OF CLINICAL FINDINGS IN COMPARISON WITH ECHOGRAPHY ANDDNA ANALYSIS
Authors: PAPADOPOULOU D TSAKIRIS D VISVARDIS G PAPADIMITRIOU M
Citation: D. Papadopoulou et al., EARLY DIAGNOSIS OF AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD) - EVALUATION OF CLINICAL FINDINGS IN COMPARISON WITH ECHOGRAPHY ANDDNA ANALYSIS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 651-651
PROSTHETIC MESH REPAIR OF MULTIPLE RECURRENT AND LARGE ABDOMINAL-HERNIAS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS
Authors: IMVRIOS G TSAKIRIS D GAKIS D TAKOUDAS D KOUKOUDIS P PAPADIMITRIOU M ANTONIADIS AA
Citation: G. Imvrios et al., PROSTHETIC MESH REPAIR OF MULTIPLE RECURRENT AND LARGE ABDOMINAL-HERNIAS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS, Peritoneal dialysis international, 14(4), 1994, pp. 338-343
WHICH IS THE BEST TIMING OF EPO ADMINISTRATION IN ANEMIA OF PREMATURITY (AOP) - RANDOMIZED CONTROLLED-STUDY
Authors: SOUBASI V KREMENOPOULOS G DIAMANTI E TSANTALI C SARAFIDIS K TSAKIRIS D
Citation: V. Soubasi et al., WHICH IS THE BEST TIMING OF EPO ADMINISTRATION IN ANEMIA OF PREMATURITY (AOP) - RANDOMIZED CONTROLLED-STUDY, Pediatric research, 36(1), 1994, pp. 10000038-10000038
ISOTOPIC STUDY OF ANEMIC PATIENTS UNDER HEMODIALYSIS BEFORE AND AFTERTREATMENT WITH ERYTHROPOIETIN (EPO)
Authors: TSAKIRIS D PAPADOPOULOU D SIOUNTAS A LAGAZALIS G KARATZAS N PAPADIMITRIOU M
Citation: D. Tsakiris et al., ISOTOPIC STUDY OF ANEMIC PATIENTS UNDER HEMODIALYSIS BEFORE AND AFTERTREATMENT WITH ERYTHROPOIETIN (EPO), Kidney international, 44(4), 1993, pp. 912-912
STUDY OF ENDOCRINE FUNCTION IN PATIENTS UNDER HEMODIALYSIS DURING THERAPY WITH ERYTHROPOIETIN
Authors: TSAKIRIS D VISVARDIS G PAPADOPOULOU D PAPADIMITRIOU M
Citation: D. Tsakiris et al., STUDY OF ENDOCRINE FUNCTION IN PATIENTS UNDER HEMODIALYSIS DURING THERAPY WITH ERYTHROPOIETIN, Kidney international, 44(4), 1993, pp. 912-912
FOLLOW-UP OF CYTOTOXIC ANTIBODIES IN HEMODIALYSIS (HD) PATIENTS DURING A 5-YEARS PERIOD
Authors: TSAKIRIS D VAKIANIS P KARAMITSOS K PAPADOPOULOU D MEMMOS D SAKELLARIOU G POLYMENIDIS A PAPADIMITRIOU M
Citation: D. Tsakiris et al., FOLLOW-UP OF CYTOTOXIC ANTIBODIES IN HEMODIALYSIS (HD) PATIENTS DURING A 5-YEARS PERIOD, Kidney international, 44(4), 1993, pp. 913-913
EPIDEMIOLOGY OF PERITONITIS AND SENSITIVITY RESISTANCE OF MICROORGANISMS DURING A 5-YEAR PERIOD OF CAPD IN ONE-CENTER
Authors: TSAKIRIS D VAKIANIS P VISVARDIS G TSATRAFILLIAS P ANTONIADOU R KYROU A PAPADIMITRIOU M
Citation: D. Tsakiris et al., EPIDEMIOLOGY OF PERITONITIS AND SENSITIVITY RESISTANCE OF MICROORGANISMS DURING A 5-YEAR PERIOD OF CAPD IN ONE-CENTER, Kidney international, 44(4), 1993, pp. 914-915
IN WHICH NEONATES DOES EARLY RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT PREVENT ANEMIA OF PREMATURITY - RESULTS OF A RANDOMIZED, CONTROLLED-STUDY
Authors: SOUBASI V KREMENOPOULOS G DIAMANDI E TSANTALI C TSAKIRIS D
Citation: V. Soubasi et al., IN WHICH NEONATES DOES EARLY RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT PREVENT ANEMIA OF PREMATURITY - RESULTS OF A RANDOMIZED, CONTROLLED-STUDY, Pediatric research, 34(5), 1993, pp. 675-679
Risultati: 1-19 |